Answer
Before starting risankizumab, patients should be evaluated for tuberculosis (TB) infection, and anti-TB therapy should be considered for those with previous latent or active TB whose adequate treatment cannot be confirmed.
Sources for this answer
- Skyrizi 150 mg solution for injection in pre-filled penAbbVie Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 11Document updated
Sources checked